The Latest Analyst Ratings for ADC Therapeutics
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 5 analysts have published their opinion on ADC Therapeutics (NYSE:ADCT) stock. The analysts have an average price target of $8.6 versus the current price of ADC Therapeutics at $0.9628, implying upside. This current average represents a 21.82% decrease from the previous average price target of $11.00.
September 12, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts predict an upside for ADC Therapeutics with an average price target of $8.6, which is significantly higher than its current price of $0.9628.
The analysts' average price target for ADC Therapeutics is significantly higher than its current price, indicating a potential upside. This could lead to an increase in the stock price in the short term. However, it's important to note that the new average price target is a 21.82% decrease from the previous one, which might indicate a less bullish outlook than before.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100